Merck Asks FDA For Emergency Authorization For Its Covid Pill
Early today, Merck and partner Ridgeback Biotherapeutics asked the Food and Drug Administration for emergency use approval for molnupiravir, meaning it may become the first oral antiviral treatment for covid. News outlets cover the story behind the drug's progress and more.